Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Drug Discov Today ; 29(5): 103954, 2024 May.
Article in English | MEDLINE | ID: mdl-38531423

ABSTRACT

The dry powder inhaler (DPI) stands out as a highly patient-friendly and effective pulmonary formulation, surpassing traditional and other pulmonary dosage forms in certain disease conditions. The development of DPI products, however, presents more complexities than that of other dosage forms, particularly in device design and the integration of the drug formulation. This review focuses on the capabilities of DPI devices in pulmonary drug delivery, with a special emphasis on device design and formulation development. It also discusses into the principles of deep lung particle deposition and device engineering, and provides a current overview of the market for DPI devices. Furthermore, the review highlights the use of computational fluid dynamics (CFD) in DPI product design and discusses the regulatory environment surrounding these devices.


Subject(s)
Drug Delivery Systems , Dry Powder Inhalers , Equipment Design , Humans , Administration, Inhalation , Hydrodynamics
2.
Curr Comput Aided Drug Des ; 15(3): 252-258, 2019.
Article in English | MEDLINE | ID: mdl-30569873

ABSTRACT

BACKGROUND: Acquired immunodeficiency Syndrome (AIDS) is caused by Human immunodeficiency virus type 1 (HIV-1). Pyrazine and Thiazolidinone pharmacophore has diverse biological activities including anti HIV activity. AIMS AND OBJECTIVES: To study binding behavior of Pyrazine- thiazolidinone derivatives on four different crystal structures of HIV- 1RT.These molecules which were already reported as anti-TB were investigated for dual activity as Anti-HIV and Anti-TB. MATERIALS AND METHODS: In the present study we describe a comparative docking study of twentythree derivatives of N-(4-oxo-2 substituted thiazolidin-3-yl) pyrazine-2-carbohydrazide. Binding pattern of these derivatives was gauged by molecular docking studies on four different receptors bearing PDB code 1ZD1, 1RT2, 1FKP and 1FK9 of HIV-RT enzyme using V. Life MDS software Genetic algorithm docking method. RESULT AND DISCUSSION: The studies revealed hydrogen bonds, hydrophobic interaction and pi-pi interactions playing significant role in binding of the molecules to the enzyme. CONCLUSION: Most of the molecules have shown good dock score and binding energy with anti-HIV receptors but Molecules 13 and 14 have potential to act as anti-tubercular and Anti HIV and hence can be further explored for dual activity.


Subject(s)
Anti-HIV Agents/chemistry , Drug Design , Pyrazines/chemistry , Thiazolidines/chemistry , Anti-HIV Agents/pharmacology , Binding Sites , Hydrogen Bonding , Molecular Docking Simulation , Pyrazines/pharmacology , Reverse Transcriptase Inhibitors/chemistry , Reverse Transcriptase Inhibitors/pharmacology , Thiazolidines/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...